Clinical trial
Botulinum Toxin Type A for Neuropathic Pain in Patients With Diabetic Peripheral Polyneuropathy
NCT02460107 is registered in ClinicalTrials.gov with Catholic University of Korea Saint Paul's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Botulinum Toxin Type A for Neuropathic Pain in Patients With Diabetic Peripheral Polyneuropathy
- Lead sponsor
- Catholic University of Korea Saint Paul's Hospital
- Phase
- Phase 1
- Overall status
- Terminated
- Start date
- May 31, 2015
- Completion date
- December 31, 2016
- Enrollment
- 9 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.